Get started
Author

Sedat Yıldırım

Observed names: Sedat YILDIRIM, Sedat Yildirim, Sedat Yıldırm
ORCID: 0000-0002-2423-6902
Observed ORCID: 0000-0002-2423-6902
OpenAlex ID: A5058443895
Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type
2007 · Nebil Bal, Sedat Yildirim, et al. · World Journal of Gastroenterology · 30
PDF
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy
2024 · Sedat Yildirim, Akif Dogan, et al. · Scientific Reports · 29
Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis
2024 · Sedat Yildirim, Ozkan Alan, et al. · Medicina · 11
PDF
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients
2024 · Sedat Yildirim, Akif Dogan, et al. · Cancers · 8
Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage
2025 · Tugba Basoglu, Ugur Ozkerim, et al. · Journal of Clinical Medicine · 7
PDF
The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric Cancer
2025 · Ezgi Turkoglu, Goncagul Akdag Topal, et al. · Medicina · 6
PDF
Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study
2025 · Ugur Ozkerim, Deniz Isik, et al. · Journal of Personalized Medicine · 5
PDF
Relationship of Tumor Localization and Lipid Parameters with Survival in Patients with Colorectal Cancer
2025 · Özlem Nuray Sever, Tuğba Başoğlu, et al. · Journal of Clinical Medicine · 4
PDF
Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study
2025 · Akif Doğan, Nurullah İlhan, et al. · Medicina · 4
PDF
Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?
2024 · Goncagul Akdag, Deniz Isik, et al. · Medicina · 4
PDF
Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience
2023 · Goncagul Akdag, Ozkan Alan, et al. · World Journal of Urology · 4
Impact of renin–angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non–small cell lung cancer
2026 · Emel Mutlu Ozkan, Ibrahim Karadağ, et al. · Expert Review of Anticancer Therapy · 3
Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study
2025 · Alper Topal, Goncagul Akdag, et al. · Medicina · 3
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study
2024 · Serhat Sekmek, Sema Nur Ozsan Çelebi, et al. · Scientific Reports · 3
Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older
2024 · Deniz ISIK, Özkan Alan, et al. · Journal of Clinical Medicine · 3
PDF
Serum Zonulin Levels in Patients with Hashimoto’s Thyroiditis
2022 · Zehra Sucuoğlu İşleyen, Sedat Yıldırım, et al. · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy · 3
PDF
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab
2026 · Gözde Ağdaş, Duygu Bayir, et al. · Scientific Reports · 2
PDF
Optimizing Antiemetic Strategies Across Phases of Chemotherapy-Induced Nausea and Vomiting: Real-World Evidence in Breast Cancer
2026 · Akif Doğan, Hande Nur Erölmez, et al. · Current Oncology · 2
PDF
Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon Cancer
2025 · Ezgi Turkoglu, Nisanur Sarıyar Busery, et al. · Journal of Clinical Medicine · 2
PDF
The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study
2025 · Seval Orman, Miray Aydoğan, et al. · Medicina · 2
PDF
Effects of Metformin on Survival and Toxicity in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab
2025 · Heves Surmeli, Sedat Yıldırım, et al. · Medicina · 2
PDF
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis
2025 · Sedat Yıldırım, Tugba Başoğlu, et al. · BMC Cancer · 2
PDF
Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer
2025 · Ezgi Turkoglu, Goncagul Akdag Topal, et al. · Breast Cancer Research and Treatment · 2
The relationship between body mass index and survival in patients with renal cell carcinoma treated with nivolumab
2025 · Rumeysa Çolak, İlkay Gültürk, et al. · Journal of Chemotherapy · 2
Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study
2024 · Deniz Işık, Oğuzcan Kınıkoğlu, et al. · Medicina · 2
PDF
Works count: 58
Citation count: 156
H-index: 6
I10-index: 3
Year
Topic
Type